ATE64095T1 - Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. - Google Patents

Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.

Info

Publication number
ATE64095T1
ATE64095T1 AT87100203T AT87100203T ATE64095T1 AT E64095 T1 ATE64095 T1 AT E64095T1 AT 87100203 T AT87100203 T AT 87100203T AT 87100203 T AT87100203 T AT 87100203T AT E64095 T1 ATE64095 T1 AT E64095T1
Authority
AT
Austria
Prior art keywords
carbon atoms
imidazochinazolines
treat
group
nephritis
Prior art date
Application number
AT87100203T
Other languages
English (en)
Inventor
Mitsutaka Takami
Original Assignee
Daiichi Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Seiyaku Co filed Critical Daiichi Seiyaku Co
Application granted granted Critical
Publication of ATE64095T1 publication Critical patent/ATE64095T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Reproductive Health (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT87100203T 1986-01-10 1987-01-09 Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis. ATE64095T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP301986 1986-01-10
EP87100203A EP0230234B1 (de) 1986-01-10 1987-01-09 Verwendung von Imidazochinazolinen zur Behandlung und Verhinderung von Nephritis

Publications (1)

Publication Number Publication Date
ATE64095T1 true ATE64095T1 (de) 1991-06-15

Family

ID=11545619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100203T ATE64095T1 (de) 1986-01-10 1987-01-09 Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.

Country Status (7)

Country Link
US (1) US4766126A (de)
EP (1) EP0230234B1 (de)
JP (1) JP2525787B2 (de)
KR (1) KR870006898A (de)
AT (1) ATE64095T1 (de)
DE (1) DE3770481D1 (de)
PH (1) PH23966A (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06509576A (ja) * 1991-07-29 1994-10-27 ワーナー−ランバート・コンパニー アセチルコリンエステラーゼ阻害剤としてのキナゾリン誘導体
US5707621A (en) * 1994-08-31 1998-01-13 Chugai Pharmaceutical Co., Ltd. Supression of nephritis-induced protein excretion by anti-IL-8

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS604186A (ja) * 1983-06-21 1985-01-10 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン化合物
JPS6028979A (ja) * 1983-07-14 1985-02-14 Dai Ichi Seiyaku Co Ltd イミダゾキナゾリン類化合物

Also Published As

Publication number Publication date
KR870006898A (ko) 1987-08-13
EP0230234B1 (de) 1991-06-05
PH23966A (en) 1990-01-23
EP0230234A1 (de) 1987-07-29
JP2525787B2 (ja) 1996-08-21
US4766126A (en) 1988-08-23
DE3770481D1 (de) 1991-07-11
JPS62252724A (ja) 1987-11-04

Similar Documents

Publication Publication Date Title
ATE103812T1 (de) Zusammensetzung zur behandlung von ischaemischen stoerungen in organen.
EA200000614A1 (ru) 2,3-замещенные соединения индола в качестве ингибиторов сох-2
DE3486150T2 (de) Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis.
ATE184483T1 (de) Spirooxathiolan-quinuclidin-derivat zur behandlung des sjögren-syndroms
DE3888340D1 (de) Verwendung von 1,4-disubstituierten-Piperidinyl-Verbindungen zur Herstellung eines Arzneimittels zur Behandlung von Schlaflosigkeit.
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
ATE64095T1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.
DE68900516D1 (de) Therapeutische mittel zur behandlung von magengeschwueren.
DE3867652D1 (de) N-substituierte 3,4-dihydropyrimidinverbindungen als mittel zur behandlung von erkrankungen des kardiovaskularen systems.
ES543802A0 (es) Procedimiento de preparacion de nuevos derivados a-etilben- zol con un grupo n-carbamiloxi sustituido
DE3762621D1 (de) Oxabicycloheptan-derivate, pharmazeutische zusammensetzung und verwendung.
DK0420224T3 (da) Anthihepatopatisk middel
ATE132038T1 (de) Verbindung zur behandlung von störungen des neurotransmittersystems im gehirn
DE69619088T2 (de) Quinoxalin-Derivate zur Behandlung von Tinnitus
DE3662039D1 (de) Novel diamine derivatives
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DK0413278T3 (da) Anvendelse af xanthinderivater mod mavesår
DE69827706D1 (de) 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.
ATE96318T1 (de) Acylaminoalkylpyridinamide als inhibitoren der tumormetastasierung.
ATE61343T1 (de) Analoga von 3-phenoxy(oder phenylthio)cyclopentancarbonylaminosaeure.